Bioavailability of prednisolone tablets
| Autor: | Aubrey V. Tembo, Donald J. Weidler, M. R. Hallmark, H G Bachmann, John G. Wagner, E. Sakmar |
|---|---|
| Rok vydání: | 1977 |
| Předmět: |
Adult
Male Chromatography Plasma samples Adult male business.industry Prednisolone Biological Availability Radioimmunoassay Bioequivalence Crossover study Bioavailability Solubility Medicine Humans Pharmacology (medical) Analysis of variance General Pharmacology Toxicology and Pharmaceutics business medicine.drug Tablets |
| Zdroj: | Journal of pharmacokinetics and biopharmaceutics. 5(3) |
| ISSN: | 0090-466X |
| Popis: | Two fourtreatment crossover studies were performed using 12 adult male volunteers in each with seven different commercially available prednisolone tablets. Plasma samples were assayed for prednisolone by a radioimmunoassay method. Statisacal analyses of the data, by analysis of variance for crossover design (ANOVA), showed no significant differences among the treatment averages at any of the sampling times except at 0.25 and 4 hr in one of the studies. There were also no significant differences among the treatment averages for peak plasma level, time of peak plasma level, area 0–12 hr, area 0–24 hr, and the halflife of elimination of prednisolone. We conclude that the average plasma concentrations of prednisolone are superimposable in a statistical sense and that the tablets tested are bioequivalent. Results of dissolution studies of six tablets of each of the seven lots of prednisolone tablets, using deaerated water in the spin filter apparatus, are presented. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink